- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 25.02. | J&J takes Samsung Bioepis to court over claims Korean company breached Stelara biosim settlement | ||
| 24.02. | In letter to RFK Jr., Democrats flag threats to drug review process from FDA firings | ||
| 24.02. | India's Granules makes $22M play for Senn Chemicals to enter peptides CDMO business | ||
| 24.02. | Lilly banks stockpile of oral GLP-1 drug with potential launch still more than a year away | ||
| 24.02. | Eli Lilly, Novo Nordisk lead revenue boom in the 'always tricky' Q4 | ||
| 21.02. | After asset purchase from Travere, Mirum's Ctexli crosses FDA finish line in rare metabolic disorder | ||
| 21.02. | Abbott's stigma-busting campaign shows how diabetes biases lead to silence, skipped care | ||
| 21.02. | Cosette sets sights on women's healthcare stardom with $430M Mayne Pharma buy | ||
| 21.02. | Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders | ||
| 21.02. | Once valued at $10B, bluebird bio sold to private equity firms for $29M | ||
| 21.02. | Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio | ||
| 21.02. | PMCPA brings the buzzkill to LinkedIn celebration, laying into GSK over employee's clicks | ||
| 20.02. | A week after RFK Jr.'s confirmation, HHS postpones vaccine committee meeting | ||
| 20.02. | Canada locks down an initial 500K doses of GSK's bird flu vaccine | ||
| 20.02. | Merck KGaA's EMD Serono taps Selma Blair to join long-running campaign for MS drug Mavenclad | ||
| 20.02. | Challenging powerhouse Pfizer, BridgeBio's launch of Attruby is off to a 'great start,' analyst says | ||
| 20.02. | Merck, plaintiff agree to hit the brakes on Gardasil trial in California | ||
| 20.02. | CDC's 'Wild to Mild' flu vaccine campaign muzzled amid HHS handover: report | ||
| 20.02. | FDA hits pair of Indian API makers with warning letters, import alerts | ||
| 20.02. | Genentech, Novartis join forces to raise awareness of food allergies' impact on families | ||
| 20.02. | AstraZeneca pays $160M for Fibrogen's China unit, regional rights to roxadustat | ||
| 19.02. | Ionis marks 'milestone event' of Tryngolza launch with first campaigns targeting patients, HCPs | ||
| 19.02. | FDA disrupts Harmony's expansion dreams for excessive sleepiness drug Wakix with refusal letter | ||
| 19.02. | After high-profile pledge to secure confirmation, RFK Jr. now says panel will review childhood vaccine schedules | ||
| 19.02. | Novartis, Roche grant CEO pay raises for 2024 as sales grew at the Swiss pharma giants |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
